Vasant (Vas) Narasimhan, who serves as the chair of PhaRMA and CEO of Novartis, had a dialogue with patient groups. Yūkiko Nishimura participated on behalf of the rare disease side and also served as the facilitator.
Vasant (Vas) Narasimhan, who serves as the chair of PhaRMA and CEO of Novartis, had a dialogue with patient groups. Yūkiko Nishimura participated on behalf of the rare disease side and also served as the facilitator.